Watson Lorna, Ellis Brian, Leng Gillian C
Cameron House, Cameron Bridge, Windygates, Leven, UK, KY8 5RG.
Cochrane Database Syst Rev. 2008 Oct 8(4):CD000990. doi: 10.1002/14651858.CD000990.pub2.
Exercise programmes are a relatively inexpensive, low-risk option compared with other more invasive therapies for leg pain on walking (intermittent claudication (IC)).
To determine the effects of exercise programmes on IC, particularly in respect of reduction of symptoms on walking and improvement in quality of life.
The Cochrane Peripheral Vascular Diseases Group searched their Specialised Register (last search February 2008) and the Cochrane Central Register of Controlled Trials (CENTRAL) in The Cochrane Library 2008, Issue 1.
Randomised controlled trials of exercise regimens in people with IC due to peripheral arterial disease.
Two authors independently extracted data and assessed trial quality.
Twenty-two trials met the inclusion criteria involving a total of 1200 participants with stable leg pain. Follow-up period was from two weeks to two years. There was some variation in the exercise regimens used, all recommended at least two sessions weekly of mostly supervised exercise. All trials used a treadmill walking test for one of the outcome measures. Quality of the included trials was good, though the majority of trials were small with 20 to 49 participants. Fourteen trials compared exercise with usual care or placebo; patients with various medical conditions or other pre-existing limitations to their exercise capacity were generally excluded.Compared with usual care or placebo, exercise significantly improved maximal walking time: mean difference (MD) 5.12 minutes (95% confidence interval (CI) 4.51 to 5.72;) with an overall improvement in walking ability of approximately 50% to 200%; exercise did not affect the ankle brachial pressure index (ABPI) (MD -0.01, 95% CI -0.05 to 0.04). Walking distances were also significantly improved: pain-free walking distance MD 82.19 metres (95% CI 71.73 to 92.65) and maximum walking distance MD 113.20 metres (95% CI 94.96 to 131.43). Improvements were seen for up to two years. The effect of exercise compared with placebo or usual care was inconclusive on mortality, amputation and peak exercise calf blood flow due to limited data.Evidence was generally limited for exercise compared with surgical intervention, angioplasty, antiplatelet therapy, pentoxifylline, iloprost and pneumatic foot and calf compression due to small numbers of trials and participants. Angioplasty may produce greater improvements than exercise in the short term but this effect may not be sustained.
AUTHORS' CONCLUSIONS: Exercise programmes were of significant benefit compared with placebo or usual care in improving walking time and distance in selected patients with leg pain from IC.
与其他治疗行走时腿部疼痛(间歇性跛行(IC))的侵入性更强的疗法相比,运动方案是一种相对廉价、低风险的选择。
确定运动方案对间歇性跛行的影响,特别是在减轻行走症状和改善生活质量方面。
Cochrane外周血管疾病小组检索了他们的专业注册库(最近一次检索时间为2008年2月)以及2008年第1期Cochrane图书馆中的Cochrane对照试验中央注册库(CENTRAL)。
针对因外周动脉疾病导致间歇性跛行的患者进行运动方案的随机对照试验。
两位作者独立提取数据并评估试验质量。
22项试验符合纳入标准,共涉及1200名有稳定腿部疼痛的参与者。随访期从两周到两年不等。所采用的运动方案存在一些差异,所有方案都建议每周至少进行两次运动,大多数情况下是在监督下进行。所有试验都将跑步机行走测试作为一项结局指标。纳入试验的质量良好,不过大多数试验规模较小,参与者为20至49人。14项试验将运动与常规护理或安慰剂进行了比较;患有各种疾病或存在其他影响运动能力的既往限制因素的患者通常被排除在外。与常规护理或安慰剂相比,运动显著改善了最大行走时间:平均差值(MD)为5.12分钟(95%置信区间(CI)为4.51至5.72);行走能力总体提高了约50%至200%;运动对踝臂压力指数(ABPI)没有影响(MD为-0.01,95%CI为-0.05至0.04)。行走距离也有显著改善:无痛行走距离MD为82.19米(95%CI为71.73至92.65),最大行走距离MD为113.20米(95%CI为94.96至131.43)。改善效果可持续长达两年。由于数据有限,运动与安慰剂或常规护理相比对死亡率、截肢和运动高峰时小腿血流的影响尚无定论。与手术干预、血管成形术、抗血小板治疗、己酮可可碱、伊洛前列素以及气动足部和小腿加压相比,由于试验和参与者数量较少,运动的证据通常有限。血管成形术可能在短期内比运动产生更大的改善,但这种效果可能无法持续。
与安慰剂或常规护理相比,运动方案对选定的因间歇性跛行导致腿部疼痛的患者在改善行走时间和距离方面具有显著益处。